Wheat Allergy
10
2
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
Randomized Controlled Trial for Wheat Oral Immunotherapy
Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care
Oral Immunotherapy for Wheat Allergy
Evaluation of Potential Allergenicity of New Wheat Varieties
Major Allergen in Wheat Anaphylaxis in Thai Population
The Natural History of Wheat Hypersensitivity in Thai Children
Oral Desensitization to Wheat in School Aged Children
Accuracy Of Skin Prick Test Using In-house Wheat Extract For The Diagnosis Of IgE-mediated Wheat Allergy: A Pilot Study